ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 184 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $34 | 0.0% | 1,586 | 0.0% | 0.00% | – |
Q2 2023 | $34 | -46.9% | 1,586 | 0.0% | 0.00% | – |
Q1 2023 | $64 | -22.0% | 1,586 | 0.0% | 0.00% | – |
Q4 2022 | $82 | -99.9% | 1,586 | 0.0% | 0.00% | – |
Q3 2022 | $82,000 | +9.3% | 1,586 | 0.0% | 0.00% | – |
Q2 2022 | $75,000 | -33.6% | 1,586 | 0.0% | 0.00% | – |
Q1 2022 | $113,000 | -85.4% | 1,586 | -87.7% | 0.00% | -100.0% |
Q3 2019 | $772,000 | -58.3% | 12,843 | -41.5% | 0.01% | -57.1% |
Q2 2019 | $1,852,000 | -16.8% | 21,947 | -5.8% | 0.01% | -22.2% |
Q1 2019 | $2,225,000 | -24.2% | 23,297 | -43.8% | 0.02% | -45.5% |
Q4 2018 | $2,934,000 | +61.7% | 41,421 | +95.2% | 0.03% | +135.7% |
Q3 2018 | $1,814,000 | – | 21,223 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |